183 related articles for article (PubMed ID: 34062166)
1. Amphiregulin increases migration and proliferation of epithelial ovarian cancer cells by inducing its own expression via PI3-kinase signaling.
Bolitho C; Moscova M; Baxter RC; Marsh DJ
Mol Cell Endocrinol; 2021 Aug; 533():111338. PubMed ID: 34062166
[TBL] [Abstract][Full Text] [Related]
2. Sprouty2 inhibits amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.
Cheng JC; Chang HM; Xiong S; So WK; Leung PC
Oncotarget; 2016 Dec; 7(49):81645-81660. PubMed ID: 27835572
[TBL] [Abstract][Full Text] [Related]
3. Sprouty4 mediates amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells.
So WK; Cheng JC; Liu Y; Xu C; Zhao J; Chang VT; Leung PC
Tumour Biol; 2016 Jul; 37(7):9197-207. PubMed ID: 26768617
[TBL] [Abstract][Full Text] [Related]
4. Amphiregulin induces human ovarian cancer cell invasion by down-regulating E-cadherin expression.
So WK; Fan Q; Lau MT; Qiu X; Cheng JC; Leung PC
FEBS Lett; 2014 Nov; 588(21):3998-4007. PubMed ID: 25261255
[TBL] [Abstract][Full Text] [Related]
5. AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway.
Wang L; Wang L; Zhang H; Lu J; Zhang Z; Wu H; Liang Z
Oncol Rep; 2020 May; 43(5):1558-1568. PubMed ID: 32323797
[TBL] [Abstract][Full Text] [Related]
6. Amphiregulin regulates proliferation and migration of HER2-positive breast cancer cells.
Schmucker H; Blanding WM; Mook JM; Wade JF; Park JP; Kwist K; Shah H; Booth BW
Cell Oncol (Dordr); 2018 Apr; 41(2):159-168. PubMed ID: 29181633
[TBL] [Abstract][Full Text] [Related]
7. Amphiregulin.
Berasain C; Avila MA
Semin Cell Dev Biol; 2014 Apr; 28():31-41. PubMed ID: 24463227
[TBL] [Abstract][Full Text] [Related]
8. Over expression of amphiregulin promoted malignant progression in gastric cancer.
Jiang J; Zhao W; Tang Q; Wang B; Li X; Feng Z
Pathol Res Pract; 2019 Oct; 215(10):152576. PubMed ID: 31466817
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer.
Hong CS; Sun EG; Choi JN; Kim DH; Kim JH; Ryu KH; Shim HJ; Hwang JE; Bae WK; Kim HR; Kim KK; Jung C; Chung IJ; Cho SH
Cancer Sci; 2020 Sep; 111(9):3268-3278. PubMed ID: 32533590
[TBL] [Abstract][Full Text] [Related]
11. Lapatinib Inhibits Amphiregulin-induced BeWo Choriocarcinoma Cell Proliferation by Reducing ERK1/2 and AKT Signaling Pathways.
Pires LV; Yi Y; Cheng JC; Pizzolato LS; Cordero E; Leung PCK; Brum IS
Anticancer Res; 2019 May; 39(5):2377-2383. PubMed ID: 31092430
[TBL] [Abstract][Full Text] [Related]
12. Reversible interconversion and maintenance of mammary epithelial cell characteristics by the ligand-regulated EGFR system.
Fukuda S; Nishida-Fukuda H; Nanba D; Nakashiro K; Nakayama H; Kubota H; Higashiyama S
Sci Rep; 2016 Feb; 6():20209. PubMed ID: 26831618
[TBL] [Abstract][Full Text] [Related]
13. Circ-PGAM1 promotes malignant progression of epithelial ovarian cancer through regulation of the miR-542-3p/CDC5L/PEAK1 pathway.
Zhang C; Li Y; Zhao W; Liu G; Yang Q
Cancer Med; 2020 May; 9(10):3500-3521. PubMed ID: 32167655
[TBL] [Abstract][Full Text] [Related]
14. HYOU1 promotes cell growth and metastasis via activating PI3K/AKT signaling in epithelial ovarian cancer and predicts poor prognosis.
Li X; Zhang NX; Ye HY; Song PP; Chang W; Chen L; Wang Z; Zhang L; Wang NN
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(10):4126-4135. PubMed ID: 31173282
[TBL] [Abstract][Full Text] [Related]
15. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
16. Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor.
Bade LK; Goldberg JE; Dehut HA; Hall MK; Schwertfeger KL
J Cell Sci; 2011 Sep; 124(Pt 18):3106-17. PubMed ID: 21868365
[TBL] [Abstract][Full Text] [Related]
17. Integrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).
Carpenter BL; Chen M; Knifley T; Davis KA; Harrison SMW; Stewart RL; O'Connor KL
J Biol Chem; 2015 Nov; 290(45):27228-27238. PubMed ID: 26381405
[TBL] [Abstract][Full Text] [Related]
18. Increased endogenous PKG I activity attenuates EGF-induced proliferation and migration of epithelial ovarian cancer via the MAPK/ERK pathway.
Lan T; Li Y; Wang Y; Wang ZC; Mu CY; Tao AB; Gong JL; Zhou Y; Xu H; Li SB; Gu B; Ma P; Luo L
Cell Death Dis; 2023 Jan; 14(1):39. PubMed ID: 36653376
[TBL] [Abstract][Full Text] [Related]
19. CD133 Stimulates Cell Proliferation via the Upregulation of Amphiregulin in Melanoma.
Simbulan-Rosenthal CM; Islam N; Haribabu Y; Alobaidi R; Shalamzari A; Graham G; Kuo LW; Sykora P; Rosenthal DS
Cells; 2024 May; 13(9):. PubMed ID: 38727313
[TBL] [Abstract][Full Text] [Related]
20. Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer.
Panupinthu N; Yu S; Zhang D; Zhang F; Gagea M; Lu Y; Grandis JR; Dunn SE; Lee HY; Mills GB
Oncogene; 2014 May; 33(22):2846-56. PubMed ID: 23851501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
